HINSILBLON, LTD. – Trademark Portfolio

Entity Type: 03

HINSILBLON, LTD. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 21 filings in this category. The portfolio also extends into Class 7 (Machinery) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include OCA19, BIO SCENT, EVANE SCENT, and AIR PROTECTOR. The owner is based in Washington, DC.

1025 Thomas Jefferson Street, N.W.

Suite 411

Washington, DC 20007

24 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HINSILBLON, LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (21 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

7
Machinery (3 filings)

Machines and machine tools; motors and engines; machine coupling and transmission components

Frequently Asked Questions

How many trademarks does HINSILBLON, LTD. have?

HINSILBLON, LTD. has 24 U.S. trademarks filed with the USPTO. Of these, 4 registered, 13 abandoned, 7 cancelled.

What trademark classes does HINSILBLON, LTD. file in?

HINSILBLON, LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 7 (Machinery). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HINSILBLON, LTD.'s most well-known trademarks?

HINSILBLON, LTD.'s registered trademark portfolio includes well-known marks such as OCA19, BIO SCENT, EVANE SCENT, and AIR PROTECTOR. These are among 4 currently registered trademarks in the portfolio.

What is HINSILBLON, LTD.'s trademark registration success rate?

HINSILBLON, LTD. has a 17% trademark registration rate, with 4 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.